Core Insights - Southbound funds reduced their holdings in HeartCare Medical-B (02160.HK) by 191,000 shares on October 15, 2025, marking a total net reduction of 856,000 shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have consistently reduced their holdings, totaling a net decrease of 1,461,000 shares [1] - As of now, southbound funds hold 111 million shares of HeartCare Medical-B, representing 4.58% of the company's total issued ordinary shares [1] Company Overview - HeartCare Medical Technology Co., Ltd. specializes in providing comprehensive medical solutions for treating structural heart diseases [2] - The company's main business involves the research and commercialization of transcatheter and surgical solutions in the field of structural heart disease [2] - The product pipeline includes transcatheter aortic valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) products, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products, and surgical accessory products [2] - The company operates in both domestic and international markets [2]
心通医疗-B（02160.HK）：10月15日南向资金减持19.1万股